Exelixis
EXEL
#1293
Rank
C$24.71 B
Marketcap
C$101.29
Share price
3.12%
Change (1 day)
74.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company